Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/791915/000079191518000041/q318pressrelease8-k.htm
April 2020
April 2020
March 2020
January 2020
December 2019
October 2019
October 2019
August 2019
August 2019
August 2019
• | Record revenue of $673.0 million, a 7.8% increase sequentially and 11.3% year-over-year |
• | GAAP and non-GAAP gross margins were 38.6% and 47.0%, respectively, and represent a 390 bps and 400 bps increase year-over-year |
• | GAAP diluted EPS increased 10 cents to $0.14 and Non-GAAP diluted EPS increased 13 cents to $0.40 year-over-year |
• | Automotive revenue increased 8.3% sequentially and 12.8% year-over-year |
GAAP1 | NON-GAAP2 | |||||||||||||||||||||||
Q3 2018 | Q2 2018 | Q3 2017 | Q3 2018 | Q2 2018 | Q3 2017 | |||||||||||||||||||
Revenue | $ | 673,035 | $ | 624,090 | $ | 604,574 | $ | 673,035 | $ | 624,090 | $ | 604,574 | ||||||||||||
Gross margin | 38.6 | % | 37.5 | % | 34.7 | % | 47.0 | % | 46.3 | % | 43.0 | % | ||||||||||||
Operating margin | 11.2 | % | 8.1 | % | 6.8 | % | 24.7 | % | 22.3 | % | 19.0 | % | ||||||||||||
Net income (loss) | $ | 50,695 | $ | 27,706 | $ | 13,016 | $ | 152,725 | $ | 124,964 | $ | 98,980 | ||||||||||||
Diluted EPS (loss) | $ | 0.14 | $ | 0.07 | $ | 0.04 | $ | 0.40 | $ | 0.33 | $ | 0.27 |
GAAP1 | NON-GAAP2 | |||||||||||||||
Nine Months | Nine Months | |||||||||||||||
Q3 2018 | Q3 2017 | Q3 2018 | Q3 2017 | |||||||||||||
Revenue | $ | 1,879,366 | $ | 1,730,224 | $ | 1,879,366 | $ | 1,730,224 | ||||||||
Gross margin | 37.6 | % | 32.3 | % | 46.4 | % | 41.1 | % | ||||||||
Operating margin | 8.6 | % | 2.1 | % | 22.3 | % | 15.7 | % | ||||||||
Net income (loss) | $ | 87,478 | $ | (46,902 | ) | $ | 377,984 | $ | 219,573 | |||||||
Diluted EPS (loss) | $ | 0.23 | $ | (0.14 | ) | $ | 1.01 | $ | 0.61 |
Three Months Ended | |||||||||||||||||
September 30, 2018 | July 1, 2018 | October 1, 2017 | Sequential Change | Year-over-year Change | |||||||||||||
Business Unit¹ | |||||||||||||||||
MCD | $ | 413,413 | $ | 368,526 | $ | 373,584 | 12.2 | % | 10.7 | % | |||||||
MPD | $ | 259,622 | $ | 255,564 | $ | 230,990 | 1.6 | % | 12.4 | % | |||||||
Total | $ | 673,035 | $ | 624,090 | $ | 604,574 | 7.8 | % | 11.3 | % |
Three Months Ended | ||||||||
September 30, 2018 | July 1, 2018 | October 1, 2017 | ||||||
End Market | ||||||||
Industrial | 19.6 | % | 19.0 | % | 17.7 | % | ||
Automotive | 31.0 | % | 30.8 | % | 30.6 | % | ||
Consumer | 32.0 | % | 31.3 | % | 34.8 | % | ||
Enterprise | 17.4 | % | 18.9 | % | 16.9 | % | ||
Total | 100 | % | 100 | % | 100 | % |
1. | The Microcontroller and Connectivity Division ("MCD") includes microcontroller, wireless connectivity and USB products and the Memory Products Division ("MPD") includes RAM, Flash and AgigA Tech products. |
GAAP¹ | Non-GAAP | |
Revenue | $585 million to $615 million | |
Gross Margin | 38.0% - 39.0% | 47.0% - 48.0% |
Diluted EPS | $0.07 to $0.11 | $0.31 to $0.35 |
• | Non-GAAP gross profit; |
• | Non-GAAP gross margin; |
• | Non-GAAP cost of revenues; |
• | Non-GAAP interest and other expense, net; |
• | Non-GAAP research and development expenses; |
• | Non-GAAP selling, general and administrative expenses; |
• | Adjusted EBITDA; |
• | Non-GAAP income tax provision (benefit); |
• | Non-GAAP pre-tax profit; |
• | Non-GAAP pre-tax profit margin; |
• | Non-GAAP operating income (loss); |
• | Non-GAAP operating margin; |
• | Non-GAAP net income (loss); |
• | Non-GAAP diluted earnings (loss) per share; and |
• | Free cash flow. |
• | Amortization of purchased intangibles, including purchased technology, patents, customer relationships, trademarks, backlog and non-compete agreements; |
• | Amortization of step-up in value of inventory recorded as part of purchase price accounting; and |
• | One-time charges associated with the completion of an acquisition including items such as contract termination costs, severance and other acquisition-related restructuring costs; costs incurred in connection with integration activities; and legal and accounting costs. |
• | Revenue from an intellectual property license; |
• | Changes in value of deferred compensation plan assets and liabilities; |
• | Investment-related gains or losses, including equity method investments; |
• | Restructuring and related costs; |
• | Debt issuance costs, including imputed interest related to the equity component of convertible debt; |
• | Asset impairments; |
• | Tax effects of non-GAAP adjustments; |
• | Income tax adjustment related to the use of the net operating loss, non-cash impact of not asserting indefinite reinvestment on earnings of our foreign subsidiaries, deferred tax expense not affecting taxes payable, and non-cash expense (benefit) related to uncertain tax positions; |
• | Certain other expenses and benefits; and |
• | Diluted weighted average shares non-GAAP adjustment - for purposes of calculating non-GAAP diluted earnings per share, the GAAP diluted weighted average shares outstanding is adjusted to include the impact of non-GAAP adjustments on the number of diluted shares underlying stock-based compensation awards and the impact of the capped call options related to the outstanding convertible notes. |
September 30, 2018 | December 31, 2017 | |||||||
ASSETS | ||||||||
Cash, cash equivalents and short-term investments | $ | 204,771 | $ | 151,596 | ||||
Accounts receivable, net | 404,561 | 295,991 | ||||||
Inventories | 289,436 | 272,127 | ||||||
Property, plant and equipment, net | 292,854 | 289,554 | ||||||
Goodwill and other intangible assets, net | 1,994,200 | 2,154,592 | ||||||
Other assets | 372,102 | 373,190 | ||||||
Total assets | $ | 3,557,924 | $ | 3,537,050 | ||||
LIABILITIES AND EQUITY | ||||||||
Accounts payable | $ | 228,159 | $ | 213,101 | ||||
Income tax liabilities | 57,283 | 52,006 | ||||||
Revenue reserves, deferred margin and other liabilities | 515,420 | 497,838 | ||||||
Revolving credit facility and long-term debt | 870,574 | 956,513 | ||||||
Total liabilities | 1,671,436 | 1,719,458 | ||||||
Total Cypress stockholders' equity | 1,885,280 | 1,816,536 | ||||||
Non-controlling interest | 1,208 | 1,056 | ||||||
Total equity | 1,886,488 | 1,817,592 | ||||||
Total liabilities and equity | $ | 3,557,924 | $ | 3,537,050 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||
September 30, 2018 | July 1, 2018 | October 1, 2017 | September 30, 2018 | October 1, 2017 | |||||||||||||||
Revenues | $ | 673,035 | $ | 624,090 | $ | 604,574 | $ | 1,879,366 | $ | 1,730,224 | |||||||||
Cost of revenue1 | 413,320 | 389,952 | 394,878 | 1,173,121 | 1,170,675 | ||||||||||||||
Gross profit | 259,715 | 234,138 | 209,696 | 706,245 | 559,549 | ||||||||||||||
Research and development1 | 91,691 | 96,693 | 90,422 | 281,617 | 268,365 | ||||||||||||||
Selling, general and administrative1 | 92,943 | 86,599 | 78,194 | 262,940 | 254,785 | ||||||||||||||
Total operating expenses | 184,634 | 183,292 | 168,616 | 544,557 | 523,150 | ||||||||||||||
Operating income | 75,081 | 50,846 | 41,080 | 161,688 | 36,399 | ||||||||||||||
Interest and other expense, net | (15,059 | ) | (14,143 | ) | (18,619 | ) | (47,356 | ) | (54,385 | ) | |||||||||
Income (loss) before income taxes and non-controlling interest | 60,022 | 36,703 | 22,461 | 114,332 | (17,986 | ) | |||||||||||||
Income tax provision | (5,618 | ) | (5,154 | ) | (4,500 | ) | (15,829 | ) | (13,930 | ) | |||||||||
Equity in net loss of equity method investees | (3,657 | ) | (3,755 | ) | (4,931 | ) | (10,873 | ) | (14,842 | ) | |||||||||
Net income (loss) | 50,747 | 27,794 | 13,030 | 87,630 | (46,758 | ) | |||||||||||||
Net gain attributable to non-controlling interests | (52 | ) | (88 | ) | (14 | ) | (152 | ) | (144 | ) | |||||||||
Net income (loss) attributable to Cypress | $ | 50,695 | $ | 27,706 | $ | 13,016 | $ | 87,478 | $ | (46,902 | ) | ||||||||
Net income (loss) per share attributable to Cypress: | |||||||||||||||||||
Basic | $ | 0.14 | $ | 0.08 | $ | 0.04 | $ | 0.24 | $ | (0.14 | ) | ||||||||
Diluted | $ | 0.14 | $ | 0.07 | $ | 0.04 | $ | 0.23 | $ | (0.14 | ) | ||||||||
Cash dividend declared per share | $ | 0.11 | $ | 0.11 | $ | 0.11 | $ | 0.33 | $ | 0.33 | |||||||||
Shares used in net income (loss) per share calculation: | |||||||||||||||||||
Basic | 361,631 | 358,577 | 332,873 | 358,560 | 329,787 | ||||||||||||||
Diluted | 374,266 | 371,967 | 360,311 | 373,064 | 329,787 |
Table A: GAAP to non-GAAP reconciling items: Three Months Ended Q3 2018 | ||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | |||||||||||||
GAAP [i] | $ | 413,320 | $ | 91,691 | $ | 92,943 | $ | (18,716 | ) | |||||||
[1] Stock-based compensation | 5,120 | 8,206 | 10,869 | — | ||||||||||||
[2] Changes in value of deferred compensation plan | 136 | 667 | 768 | (1,108 | ) | |||||||||||
[3] Equity in net loss of equity method investees | — | — | — | 3,657 | ||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 6,782 | ||||||||||||
[5] Amortization of acquisition-related intangible assets and other | 51,565 | — | 4,310 | — | ||||||||||||
[6] Acquisition costs | — | — | 119 | — | ||||||||||||
[7] Restructuring charges | (340 | ) | 516 | 9,815 | — | |||||||||||
[8] Litigation settlement and other | — | — | (605 | ) | (1,286 | ) | ||||||||||
Non - GAAP [ii] | $ | 356,839 | $ | 82,302 | $ | 67,667 | $ | (10,671 | ) | |||||||
Impact of reconciling items [ii - i] | $ | (56,481 | ) | $ | (9,389 | ) | $ | (25,276 | ) | $ | 8,045 |
Table B: GAAP to non-GAAP reconciling items: Three Months Ended Q2 2018 | ||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | |||||||||||||
GAAP [i] | $ | 389,952 | $ | 96,693 | $ | 86,599 | $ | (17,898 | ) | |||||||
[1] Stock-based compensation | 3,986 | 13,800 | 16,121 | — | ||||||||||||
[2] Changes in value of deferred compensation plan | 102 | 467 | 572 | (1,123 | ) | |||||||||||
[3] Equity in net loss of equity method investees | — | — | — | 3,755 | ||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 4,415 | ||||||||||||
[5] Amortization of acquisition-related intangible assets and other | 49,438 | — | 4,355 | — | ||||||||||||
[6] Gain on sale of cost method investment | — | — | (1,521 | ) | — | |||||||||||
[7] Restructuring charges and other | 1,589 | 33 | (383 | ) | (377 | ) | ||||||||||
Non - GAAP [ii] | $ | 334,837 | $ | 82,393 | $ | 67,455 | $ | (11,228 | ) | |||||||
Impact of reconciling items [ii - i] | $ | (55,115 | ) | $ | (14,300 | ) | $ | (19,144 | ) | $ | 6,670 |
Table C: GAAP to Non-GAAP reconciling items: Three Months Ended Q3 2017 | ||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | |||||||||||||
GAAP [i] | $ | 394,878 | $ | 90,422 | $ | 78,194 | $ | (23,550 | ) | |||||||
[1] Stock-based compensation | 4,720 | 8,692 | 7,600 | — | ||||||||||||
[2] Changes in value of deferred compensation plan | 208 | 1,278 | 1,415 | (1,734 | ) | |||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 1,336 | — | (636 | ) | — | |||||||||||
[4] Inventory step-up related to acquisition accounting | 704 | — | — | — | ||||||||||||
[5] Equity in net loss and impairment of equity method investees | — | — | — | 4,931 | ||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 3,521 | ||||||||||||
[7] Write-off of unamortized debt issuance costs related to Term Loan A | — | — | — | 2,996 | ||||||||||||
[8] Amortization of debt issuance costs | — | — | — | 856 | ||||||||||||
[9] Amortization of acquisition-related intangible assets and other | 43,345 | — | 5,083 | 51 | ||||||||||||
Non - GAAP [ii] | $ | 344,565 | $ | 80,452 | $ | 64,732 | $ | (12,929 | ) | |||||||
Impact of reconciling items [ii - i] | $ | (50,313 | ) | $ | (9,970 | ) | $ | (13,462 | ) | $ | 10,621 |
Table D: GAAP to non-GAAP reconciling items: Nine Months Ended Q3 2018 | ||||||||||||||||
Cost of revenues | Research and development | SG&A and Restructuring costs | Interest and other expense, net | |||||||||||||
GAAP [i] | $ | 1,173,121 | $ | 281,617 | $ | 262,940 | $ | (58,229 | ) | |||||||
[1] Stock-based compensation | 12,689 | 28,720 | 35,152 | — | ||||||||||||
[2] Changes in value of deferred compensation plan | 299 | 1,406 | 1,690 | (2,497 | ) | |||||||||||
[3] Equity in net loss and impairment of equity method investees | — | — | — | 10,873 | ||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 14,628 | ||||||||||||
[5] Loss on extinguishment of Spansion convertible notes and debt issuance cost write off due to refinancing | — | — | — | 3,258 | ||||||||||||
[6] Amortization of debt issuance costs | — | — | — | 1,073 | ||||||||||||
[7] Amortization of acquisition-related intangible assets and other | 150,441 | — | 13,815 | — | ||||||||||||
[8] Gain on sale of cost method investment | — | — | (1,521 | ) | — | |||||||||||
[9] Acquisition costs | — | — | 119 | — | ||||||||||||
[10] Restructuring charges | 3,136 | 841 | 11,347 | — | ||||||||||||
[11] Litigation settlement and other | — | — | (605 | ) | (1,270 | ) | ||||||||||
Non - GAAP [ii] | $ | 1,006,556 | $ | 250,650 | $ | 202,943 | $ | (32,164 | ) | |||||||
Impact of reconciling items [ii - i] | $ | (166,565 | ) | $ | (30,967 | ) | $ | (59,997 | ) | $ | 26,065 |
Table E: GAAP to non-GAAP reconciling items: Nine Months Ended Q3 2017 | ||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | |||||||||||||
GAAP [i] | $ | 1,170,675 | $ | 268,365 | $ | 254,785 | $ | (69,227 | ) | |||||||
[1] Stock-based compensation | 12,605 | 28,754 | 27,157 | — | ||||||||||||
[2] Changes in value of deferred compensation plan | 512 | 2,438 | 3,319 | (4,876 | ) | |||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 4,022 | (96 | ) | (922 | ) | — | ||||||||||
[4] Inventory step-up related to acquisition accounting | 3,735 | — | — | — | ||||||||||||
[5] Equity in net loss and impairment of equity method investees | — | — | — | 14,842 | ||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 10,517 | ||||||||||||
[7] Write-off of unamortized debt issuance costs related to Term Loan A | — | — | — | 2,996 | ||||||||||||
[8] Amortization of debt issuance costs | — | — | — | 2,634 | ||||||||||||
[9] Amortization of acquisition-related intangible assets | 130,782 | — | 15,250 | — | ||||||||||||
[10] Restructuring charges | 231 | 2,710 | 528 | — | ||||||||||||
[11] Settlement charges and other | — | — | 3,500 | 693 | ||||||||||||
Non - GAAP [ii] | $ | 1,018,788 | $ | 234,559 | $ | 205,953 | $ | (42,421 | ) | |||||||
Impact of reconciling items [ii - i] | $ | (151,887 | ) | $ | (33,806 | ) | $ | (48,832 | ) | $ | 26,806 |
Table F: Non-GAAP gross profit | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP gross profit | $ | 259,715 | $ | 234,138 | $ | 209,696 | $ | 706,245 | $ | 559,549 | ||||||||||
Impact of reconciling items on cost of revenues (Table A, B, C, D and E) | 56,481 | 55,115 | 50,313 | 166,565 | 151,887 | |||||||||||||||
Non-GAAP gross profit | $ | 316,196 | $ | 289,253 | $ | 260,009 | $ | 872,810 | $ | 711,436 | ||||||||||
GAAP gross margin (GAAP gross profit/revenue) | 38.6 | % | 37.5 | % | 34.7 | % | 37.6 | % | 32.3 | % | ||||||||||
Non-GAAP gross margin (Non-GAAP gross profit/revenue) | 47.0 | % | 46.3 | % | 43.0 | % | 46.4 | % | 41.1 | % |
Table G: Non-GAAP operating income | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP operating income [i] | $ | 75,081 | $ | 50,846 | $ | 41,080 | $ | 161,688 | $ | 36,399 | ||||||||||
Impact of reconciling items on cost of revenues (see Table A, B, C, D, E) | 56,481 | 55,115 | 50,313 | 166,565 | 151,887 | |||||||||||||||
Impact of reconciling items on R&D (see Table A, B, C, D, E) | 9,389 | 14,300 | 9,970 | 30,967 | 33,806 | |||||||||||||||
Impact of reconciling items on SG&A (see Table A, B, C, D, E) | 25,276 | 19,144 | 13,462 | 59,997 | 48,832 | |||||||||||||||
Non-GAAP operating income [ii] | $ | 166,227 | $ | 139,405 | $ | 114,825 | $ | 419,217 | $ | 270,924 | ||||||||||
Impact of reconciling items on operating income [ii - i] | $ | 91,146 | $ | 88,559 | $ | 73,745 | $ | 257,529 | $ | 234,525 | ||||||||||
GAAP operating margin (GAAP operating income / revenue) | 11.2 | % | 8.1 | % | 6.8 | % | 8.6 | % | 2.1 | % | ||||||||||
Non-GAAP operating margin (Non-GAAP operating income / revenue) | 24.7 | % | 22.3 | % | 19.0 | % | 22.3 | % | 15.7 | % |
Table H: Non-GAAP pre-tax profit | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP income (loss) before income taxes and non-controlling interest ("Pre-tax income") | $ | 60,022 | $ | 36,703 | $ | 22,461 | $ | 114,332 | $ | (17,986 | ) | |||||||||
Equity in net loss and impairment of equity method investees | (3,657 | ) | (3,755 | ) | (4,931 | ) | (10,873 | ) | (14,842 | ) | ||||||||||
Impact of reconciling items on operating income (see Table G) | 91,146 | 88,559 | 73,745 | 257,529 | 234,525 | |||||||||||||||
Impact of reconciling items on interest and other expense, net (see Table A, B, C, D, E) | 8,045 | 6,670 | 10,621 | 26,065 | 26,806 | |||||||||||||||
Non-GAAP pre-tax profit | $ | 155,556 | $ | 128,177 | $ | 101,896 | $ | 387,053 | $ | 228,503 | ||||||||||
GAAP pre-tax profit margin (GAAP pre-tax income/revenue) | 8.9 | % | 5.9 | % | 3.7 | % | 6.1 | % | (1.0 | )% | ||||||||||
Non-GAAP pre-tax profit margin (Non-GAAP pre-tax profit/revenue) | 23.1 | % | 20.5 | % | 16.9 | % | 20.6 | % | 13.2 | % |
Table I: Non-GAAP income tax expense | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP income tax provision [i] | 5,618 | 5,154 | 4,500 | 15,829 | 13,930 | |||||||||||||||
[1] Stock-based compensation | 5,081 | 7,120 | 7,354 | 16,078 | 23,981 | |||||||||||||||
[2] Changes in value of deferred compensation plan | 97 | 4 | 408 | 189 | 488 | |||||||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | — | — | 245 | — | 1,051 | |||||||||||||||
[4] Inventory step-up related to acquisition accounting | — | — | 246 | — | 1,314 | |||||||||||||||
[5] Equity in net loss and impairment of equity method investees | 768 | 789 | 1,726 | 2,283 | 5,195 | |||||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | 1,424 | 927 | 1,232 | 3,072 | 3,681 | |||||||||||||||
[7] Amortization of debt issuance costs | — | — | 300 | 225 | 922 | |||||||||||||||
[8] Amortization of acquisition-related intangible assets and other | 11,734 | 11,297 | 16,950 | 34,494 | 51,111 | |||||||||||||||
[9] Restructuring charges | 2,098 | 260 | — | 3,218 | 1,214 | |||||||||||||||
[10] Settlement charges | — | — | — | — | 1,225 | |||||||||||||||
[11] Loss on extinguishment of Spansion convertible notes | — | — | 1,049 | 684 | 1,049 | |||||||||||||||
[12] Gain on sale of cost method investment | — | (319 | ) | — | (319 | ) | — | |||||||||||||
[13] Uncertain tax positions | (2,159 | ) | (1,348 | ) | (663 | ) | (4,870 | ) | (2,458 | ) | ||||||||||
[14] Utilization of NOL including excess tax benefits, and others** | (21,882 | ) | (20,759 | ) | (30,445 | ) | (61,966 | ) | (93,917 | ) | ||||||||||
Non-GAAP income tax expense [ii]* | $ | 2,779 | $ | 3,125 | $ | 2,902 | $ | 8,917 | $ | 8,786 | ||||||||||
Impact of reconciling items on income tax provision [i - ii] | 2,839 | 2,029 | 1,598 | 6,912 | 5,144 |
Table J: Non-GAAP net income | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP net income (loss) attributable to Cypress | $ | 50,695 | $ | 27,706 | $ | 13,016 | $ | 87,478 | $ | (46,902 | ) | |||||||||
Impact of reconciling items on operating income (see Table G) | 91,146 | 88,559 | 73,745 | 257,529 | 234,525 | |||||||||||||||
Impact of reconciling items on interest and other expense, net (see Table A, B, C, D, E) | 8,045 | 6,670 | 10,621 | 26,065 | 26,806 | |||||||||||||||
Impact of reconciling items on income tax provision (see Table I) | 2,839 | 2,029 | 1,598 | 6,912 | 5,144 | |||||||||||||||
Non-GAAP net income | $ | 152,725 | $ | 124,964 | $ | 98,980 | $ | 377,984 | $ | 219,573 |
Table K: Weighted-average shares, diluted | ||||||||||||||||||
Three Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | ||||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Weighted-average common shares outstanding, basic | 361,631 | 361,631 | 358,577 | 358,577 | 332,873 | 332,873 | ||||||||||||
Effect of dilutive securities: | ||||||||||||||||||
Stock options, unvested restricted stock and other | 7,096 | 12,468 | 7,837 | 14,391 | 7,884 | 12,948 | ||||||||||||
Convertible notes | 5,539 | 3,234 | 5,553 | 3,070 | 19,554 | 18,790 | ||||||||||||
Weighted-average common shares outstanding, diluted | 374,266 | 377,333 | 371,967 | 376,038 | 360,311 | 364,611 |
Table L: Weighted-average shares, diluted | ||||||||||||
Nine Months Ended | ||||||||||||
Q3'18 | Q3'17 | |||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||
Weighted-average common shares outstanding, basic | 358,560 | 358,560 | 329,787 | 329,787 | ||||||||
Effect of dilutive securities: | ||||||||||||
Stock options, unvested restricted stock and other | 8,378 | 13,557 | — | 13,060 | ||||||||
Convertible notes | 6,126 | 3,852 | — | 18,370 | ||||||||
Weighted-average common shares outstanding, diluted | 373,064 | 375,969 | 329,787 | 361,217 |
Table M: Earnings per share | ||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | ||||||||||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||||||||
Net income (see Table J) [i] | $ | 50,695 | $ | 152,725 | $ | 27,706 | $ | 124,964 | $ | 13,016 | $ | 98,980 | ||||||||||||
Weighted-average common shares outstanding, diluted (see Table K) [ii] | 374,266 | 377,333 | 371,967 | 376,038 | 360,311 | 364,611 | ||||||||||||||||||
Earnings per share - diluted [i/ii] | $ | 0.14 | $ | 0.40 | $ | 0.07 | $ | 0.33 | $ | 0.04 | $ | 0.27 |
Table N: Earnings (loss) per share | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
Q3'18 | Q3'17 | |||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Net income (loss) (see Table J) [i] | $ | 87,478 | $ | 377,984 | $ | (46,902 | ) | $ | 219,573 | |||||||
Weighted-average common shares outstanding, diluted (see Table L) [ii] | 373,064 | 375,969 | 329,787 | 361,217 | ||||||||||||
Earnings (loss) per share - diluted [i/ii] | $ | 0.23 | $ | 1.01 | $ | (0.14 | ) | $ | 0.61 |
Table O: Adjusted EBITDA | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP net income (loss) attributable to Cypress | $ | 50,695 | $ | 27,706 | $ | 13,016 | $ | 87,478 | $ | (46,902 | ) | |||||||||
Interest and other expense, net | (15,059 | ) | (14,143 | ) | (18,619 | ) | (47,356 | ) | (54,385 | ) | ||||||||||
Income tax provision | (5,618 | ) | (5,154 | ) | (4,500 | ) | (15,829 | ) | (13,930 | ) | ||||||||||
Equity in net loss of and impairment of equity method investees | (3,657 | ) | (3,755 | ) | (4,931 | ) | (10,873 | ) | (14,842 | ) | ||||||||||
Net gain (loss) attributable to non-controlling interests | (52 | ) | (88 | ) | (14 | ) | (152 | ) | (144 | ) | ||||||||||
GAAP operating income | $ | 75,081 | $ | 50,846 | $ | 41,080 | $ | 161,688 | $ | 36,399 | ||||||||||
Impact of reconciling items on operating income (see Table G) | 91,146 | 88,559 | 73,745 | 257,529 | 234,525 | |||||||||||||||
Non-GAAP operating income | $ | 166,227 | $ | 139,405 | $ | 114,825 | $ | 419,217 | $ | 270,924 | ||||||||||
Depreciation | 16,393 | 16,239 | 16,674 | 49,772 | 48,876 | |||||||||||||||
Adjusted EBITDA | $ | 182,620 | $ | 155,644 | $ | 131,499 | $ | 468,989 | $ | 319,800 |
Table P: Free cash flow | Three Months Ended | Nine Months Ended | ||||||||||||||||||
Q3'18 | Q2'18 | Q3'17 | Q3'18 | Q3'17 | ||||||||||||||||
GAAP net cash provided by operating activities | $ | 187,073 | $ | 110,734 | $ | 143,778 | $ | 329,485 | $ | 201,946 | ||||||||||
Acquisition of property, plant and equipment, net | (15,448 | ) | (25,590 | ) | (15,975 | ) | (58,061 | ) | (44,154 | ) | ||||||||||
Free cash flow | $ | 171,625 | $ | 85,144 | $ | 127,803 | $ | 271,424 | $ | 157,792 |
Three Months Ended | Nine Months Ended | |||||||||||||||||||
September 30, 2018 | July 1, 2018 | October 1, 2017 | September 30, 2018 | October 1, 2017 | ||||||||||||||||
Selected Cash Flow Data (Preliminary): | ||||||||||||||||||||
Net cash provided by operating activities | $ | 187,073 | $ | 110,734 | $ | 143,778 | $ | 329,485 | $ | 201,946 | ||||||||||
Net cash (used in) provided by investing activities | $ | (22,316 | ) | $ | (7,213 | ) | $ | (15,051 | ) | $ | (43,700 | ) | $ | (8,393 | ) | |||||
Net cash used in financing activities | $ | (72,730 | ) | $ | (97,556 | ) | $ | (105,935 | ) | $ | (232,634 | ) | $ | (182,162 | ) | |||||
Other Supplemental Data (Preliminary): | ||||||||||||||||||||
Capital expenditures, net | $ | 15,448 | $ | 25,590 | $ | 15,975 | $ | 58,061 | $ | 44,154 | ||||||||||
Depreciation | $ | 16,393 | $ | 16,239 | $ | 16,674 | $ | 49,772 | $ | 48,876 | ||||||||||
Payment of dividend | $ | 39,447 | $ | 39,404 | $ | 36,325 | $ | 117,592 | $ | 108,079 | ||||||||||
Dividend paid per share | $ | 0.11 | $ | 0.11 | $ | 0.11 | $ | 0.33 | $ | 0.33 | ||||||||||
Total debt (principal amount) | $ | 936,518 | $ | 955,553 | $ | 1,205,790 | $ | 936,518 | $ | 1,205,790 | ||||||||||
Leverage ratio | 1.54 | 1.71 | 2.91 | 1.54 | 2.91 | |||||||||||||||
Cash Income Tax | 2,779 | 3,125 | 2,902 | 8,917 | 8,786 |
Forward-looking GAAP estimate (A)¹ | Adjustments (B) | Forward-looking Non-GAAP estimate (C)=(A)+(B) | ||||||||||||||
Amortization of intangibles | Stock-based compensation expense | Other items | ||||||||||||||
Gross margin | 38.0% - 39.0% | 8.4 | % | 0.4 | % | 0.2 | % | 47.0% - 48.0% | ||||||||
Diluted earnings per share | $0.07 to $0.11 | $ | 0.15 | $ | 0.06 | $ | 0.03 | $0.31 to $0.35 |
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/791915/000079191518000041/q318pressrelease8-k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cypress Semiconductor Corp.
Cypress Semiconductor Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Cypress Semiconductor Corp provided additional information to their SEC Filing as exhibits
Ticker: CYEvents:
CIK: 791915
Form Type: 8-K Corporate News
Accession Number: 0000791915-18-000041
Submitted to the SEC: Thu Oct 25 2018 4:21:48 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Semiconductors And Related Devices